CLGN

CollPlant Biotechnologies Ltd

4.14

Oct 30 • 3:59 PM ET -0.26 (-6.02%)

4.10

Aftermarket • 7:30 PM ET -0.04 (-0.85%)

Healthcare Biotechnology Israel Nano NASD

Peers: PLX DYAI MLEC HUMA FBLG MDXG BSEM VCEL BBLG EVGN

Scroll to Statements

Index	-
Market Cap	7.82M
Enterprise Value	7.53M
Income	-12.51M
Sales	0.32M
Book/sh	2.04
Cash/sh	1.56
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	39
IPO	May 21, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	24.42
P/B	2.03
P/C	2.65
P/FCF	-
EV/EBITDA	-
EV/Sales	23.52
Quick Ratio	1.35
Current Ratio	1.57
Debt/Eq	0.90
LT Debt/Eq	0.60
Option/Short	No / Yes

EPS (ttm)	-9.38
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	15.02% -2.35%
Sales past 3/5Y	99.41% -17.32%
EPS Y/Y TTM	16.63%
Sales Y/Y TTM	-86.76%
EPS Q/Q	33.15%
Sales Q/Q	-39.66%
Earnings	Sep 30 AMC
EPS/Sales Surpr.	- -

Insider Own	17.54%
Insider Trans	0.00%
Inst Own	8.73%
Inst Trans	-1.45%
ROA	-101.59%
ROE	-161.98%
ROIC	-265.61%
Gross Margin	-587.74%
Oper. Margin	-3900.94%
Profit Margin	-3934.91%
SMA20	9.21%
SMA50	12.08%
SMA200	-19.07%
Trades

Shs Outstand	1.89M
Shs Float	1.56M
Short Float	3.38%
Short Ratio	0.15
Short Interest	0.05M
52W High	22.90 -81.94%
52W Low	2.64 56.81%
Volatility	11.30% 11.02%
ATR (14)	0.42
RSI (14)	56.23
Beta	0.62
Rel Volume	0.12
Avg Volume	360.37K
Volume	44,258

Perf Week	12.67%
Perf Month	15.83%
Perf Quarter	30.03%
Perf Half Y	0.70%
Perf YTD	-70.46%
Perf Year	-81.12%
Perf 3Y	-91.85%
Perf 5Y	-98.12%
Perf 10Y	-97.69%
Recom	3.00
Target Price	120.00
Prev Close	4.40
Price	4.14
Change %	-6.02%

Consensus

Hold

Avg. Price Target

$120.00

Implied Upside

+2,802.1%

Analysts1incl. previous ratings

Rating Distribution1 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Feb 17, 2023	Initiated	AAlliance Global Partners	Buy	$22.75	+450.2%

Oct-20-26 08:30AM	LightSolver and Why AI May Outrun the GPU (NASDAQ: CLGN) (FinanceWire) +8.99%
Oct-09-26 09:00AM	COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT (PR Newswire) -11.59%
Oct-06-26 07:00AM	LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations (PR Newswire)
Sep-30-26 05:20PM	COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire) -5.56%
Sep-24-26 08:00AM	LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads (PR Newswire)
07:30AM	Loading…
Sep-22-26 07:30AM	CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) -10.47%
Sep-10-26 07:00AM	CollPlant to Host LightSolver Investor Webinar on September 17, 2026 (PR Newswire)
Sep-04-26 08:26AM	COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION (PR Newswire)
Sep-03-26 08:00AM	COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR (PR Newswire)
Sep-01-26 04:01PM	COLLPLANT ANNOUNCES REVERSE SHARE SPLIT (PR Newswire) -7.86%
Aug-31-26 08:00AM	COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS (PR Newswire) +8.35%
Jun-30-26 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT (PR Newswire)
May-29-26 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Apr-13-26 07:00AM	CollPlant Issues Letter to Shareholders (PR Newswire) -15.71%
Mar-26-26 08:30AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire) -12.02%
04:01PM	Loading…
Mar-24-26 04:01PM	CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement (PR Newswire) +17.15% +5.50%
Mar-18-26 09:00AM	CollPlant Biotechnologies Launches Redesigned Corporate Website (PR Newswire)
Mar-11-26 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS (PR Newswire)
Feb-26-26 08:00AM	CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler (PR Newswire)
Feb-23-26 07:00AM	CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex (PR Newswire)
Feb-17-26 07:00AM	CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments (PR Newswire) -11.93%
Feb-06-26 08:06AM	CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering (TipRanks) +6.65%
Feb-05-26 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING (PR Newswire) -53.42%
Nov-26-25 07:30AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Nov-18-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS (PR Newswire)
Oct-27-25 07:01AM	CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada (PR Newswire)
Oct-20-25 07:00AM	CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel in Study Conducted by Technion - Israel Institute of Technology (PR Newswire) +7.33%
Oct-16-25 07:00AM	First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk (PR Newswire)
Sep-30-25 07:00AM	CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler (PR Newswire) -12.94%
Sep-02-25 07:00AM	CollPlant to Present at the 2025 International Conference on Biofabrication (PR Newswire)
07:00AM	Loading…
Aug-25-25 07:00AM	CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference (PR Newswire)
Aug-20-25 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire) -20.20%
Aug-19-25 09:22AM	Earnings To Watch: CollPlant Biotechnologies Ltd (CLGN) Reports Q2 2025 Result (GuruFocus.com) -7.33%
Aug-05-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS (PR Newswire)
Jul-14-25 07:00AM	CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations (PR Newswire) +15.28%
Jun-09-25 07:00AM	COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES (PR Newswire) -10.82%
Jun-04-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS (PR Newswire) -13.39%
May-30-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES (PR Newswire) -29.96%
May-28-25 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE (PR Newswire) +76.17%
May-14-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS (PR Newswire) +5.48%
Apr-15-25 08:00AM	CollPlant's Collink.3D BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies (PR Newswire)
Mar-26-25 07:58PM	CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript (SeekingAlpha)
08:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE (PR Newswire)
Mar-25-25 09:05AM	What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings (GuruFocus.com) -9.68%
Mar-19-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Feb-24-25 07:00AM	CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia (PR Newswire) -6.05%
Feb-12-25 06:00AM	CollPlant Biotechnologies Provides a Corporate Update (PR Newswire)
Nov-27-24 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Nov-26-24 07:01AM	What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings (GuruFocus.com)
Nov-12-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire) +10.80%
Aug-20-24 11:52AM	CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
07:28AM	CollPlant Biotechnologies Posts Loss In Q2 - Quick Facts (RTT News)
07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Aug-19-24 08:30AM	CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants (PR Newswire) +5.48%
Aug-06-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Jul-29-24 07:00AM	CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report (PR Newswire)
Jun-06-24 07:00AM	CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data (PR Newswire)
May-30-24 08:02AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-29-24 11:53AM	CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00AM	CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update (PR Newswire)
May-16-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
May-10-24 09:51AM	CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock? (Zacks)
Apr-08-24 09:19AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-04-24 11:52AM	CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:17AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Mar-26-24 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Feb-15-24 08:00AM	CollPlant Issues Letter to Shareholders (PR Newswire)
Jan-08-24 07:18AM	CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California (PR Newswire)
Jan-02-24 07:00AM	CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants (PR Newswire) -5.32%
Dec-01-23 09:58AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-29-23 07:00AM	CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023 (PR Newswire) -6.63%
Nov-09-23 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Nov-01-23 07:05AM	CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler (PR Newswire) +24.11%
Sep-21-23 07:00AM	CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative (PR Newswire)
Sep-05-23 07:00AM	CollPlant to Present at the H.C. Wainwright Annual Growth Conference (PR Newswire)
Aug-24-23 07:00AM	CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million (PR Newswire) +6.87%
Aug-09-23 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Jun-26-23 07:00AM	CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement (PR Newswire)
May-24-23 07:00AM	CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update (PR Newswire) +5.69%
May-02-23 09:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Apr-04-23 08:26AM	Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs (Business Wire) +5.28%
Mar-29-23 07:00AM	Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update (PR Newswire) -9.89%
Mar-14-23 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire) +7.93%
Jan-24-23 07:00AM	CollPlant Issues Letter to Shareholders (PR Newswire)
Jan-04-23 07:00AM	CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives (PR Newswire) +9.65%
Jan-03-23 07:00AM	CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form (PR Newswire)
Dec-12-22 09:50AM	We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth (Simply Wall St.) +6.58%
Dec-01-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results (PR Newswire)
Nov-15-22 07:00AM	CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis (PR Newswire)
Nov-07-22 07:00AM	CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D 90 (PR Newswire) -5.80%
Nov-03-22 07:00AM	CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17 (PR Newswire)
Oct-03-22 07:00AM	CollPlant to present at the Dawson James Small Cap Growth Conference on October 12 (PR Newswire)
Sep-19-22 07:00AM	CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy (PR Newswire)
Sep-06-22 07:00AM	CollPlant Biotechnologies to Participate in September Investor Conferences (PR Newswire)
Aug-25-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results (PR Newswire)
Jul-05-22 10:27AM	We're Hopeful That CollPlant Biotechnologies (NASDAQ:CLGN) Will Use Its Cash Wisely (Simply Wall St.)
07:00AM	CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada (PR Newswire)
Jun-29-22 08:45AM	CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study (PR Newswire) +10.54%
May-26-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results (PR Newswire)
May-23-22 08:00AM	Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Loewenbaum Lilian S.	10% Owner	Oct 27 '26	Proposed Sale	3.79	15,550	58,934		Oct 27 11:25 AM

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

CEO & ChairmanMr. Yehiel Tal

Deputy CEO & CFOMr. Eran Rotem CPA

Vice President of OperationsMr. Oren Fahimipoor

Founder & Chief ScientistDr. Oded Shoseyov

Vice President of LegalMs. Bar Abelis

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CLGN

CollPlant Biotechnologies Ltd

Upgrade your Finviz experience